219 related articles for article (PubMed ID: 27708237)
1. Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy.
Hao J; Graham P; Chang L; Ni J; Wasinger V; Beretov J; Deng J; Duan W; Bucci J; Malouf D; Gillatt D; Li Y
Oncotarget; 2016 Nov; 7(45):74269-74285. PubMed ID: 27708237
[TBL] [Abstract][Full Text] [Related]
2. Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach.
Chang L; Ni J; Beretov J; Wasinger VC; Hao J; Bucci J; Malouf D; Gillatt D; Graham PH; Li Y
Sci Rep; 2017 Feb; 7():41834. PubMed ID: 28225015
[TBL] [Abstract][Full Text] [Related]
3. Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo.
Ni J; Cozzi P; Beretov J; Duan W; Bucci J; Graham P; Li Y
BMC Cancer; 2018 Nov; 18(1):1092. PubMed ID: 30419852
[TBL] [Abstract][Full Text] [Related]
4. Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate cancer to radiotherapy.
Koukourakis MI; Giatromanolaki A; Panteliadou M; Pouliliou SE; Chondrou PS; Mavropoulou S; Sivridis E
Br J Cancer; 2014 Apr; 110(9):2217-23. PubMed ID: 24714743
[TBL] [Abstract][Full Text] [Related]
5. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of LDHA suppresses tumor progression in prostate cancer.
Xian ZY; Liu JM; Chen QK; Chen HZ; Ye CJ; Xue J; Yang HQ; Li JL; Liu XF; Kuang SJ
Tumour Biol; 2015 Sep; 36(10):8093-100. PubMed ID: 25983002
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor pathway promotes glycolysis by activating LDHA and suppressing LDHB in a STAT1-dependent manner in prostate cancer.
Ye Y; Yang F; Gu Z; Li W; Yuan Y; Liu S; Zhou L; Han B; Zheng R; Cao Z
J Transl Med; 2024 May; 22(1):474. PubMed ID: 38764020
[TBL] [Abstract][Full Text] [Related]
8. RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.
Young A; Berry R; Holloway AF; Blackburn NB; Dickinson JL; Skala M; Phillips JL; Brettingham-Moore KH
BMC Cancer; 2014 Nov; 14():808. PubMed ID: 25369795
[TBL] [Abstract][Full Text] [Related]
9. TAB182 regulates glycolytic metabolism by controlling LDHA transcription to impact tumor radiosensitivity.
Chen S; Xie DF; Li S; Luo J; Han Y; Guo H; Gao S; Huang X; Guan H; Huang R; Zhou PK
Cell Death Dis; 2024 Mar; 15(3):209. PubMed ID: 38480704
[TBL] [Abstract][Full Text] [Related]
10. MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.
Li H; Li X; Ge X; Jia L; Zhang Z; Fang R; Yang J; Liu J; Peng S; Zhou M; Xiang J; Zeng Z; Zhou W; Xiong W; Xiao G; Fang L; Li GY; Li Z
Oncotarget; 2016 Aug; 7(34):54838-54851. PubMed ID: 27458165
[TBL] [Abstract][Full Text] [Related]
11. CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo.
Ni J; Cheung BB; Beretov J; Duan W; Bucci J; Malouf D; Graham P; Li Y
Exp Cell Res; 2020 Mar; 388(2):111850. PubMed ID: 31954695
[TBL] [Abstract][Full Text] [Related]
12. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
[TBL] [Abstract][Full Text] [Related]
13. miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition.
El Bezawy R; Tinelli S; Tortoreto M; Doldi V; Zuco V; Folini M; Stucchi C; Rancati T; Valdagni R; Gandellini P; Zaffaroni N
J Exp Clin Cancer Res; 2019 Feb; 38(1):51. PubMed ID: 30717752
[TBL] [Abstract][Full Text] [Related]
14. CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance.
Ni J; Cozzi PJ; Hao JL; Beretov J; Chang L; Duan W; Shigdar S; Delprado WJ; Graham PH; Bucci J; Kearsley JH; Li Y
Prostate; 2014 May; 74(6):602-17. PubMed ID: 24615685
[TBL] [Abstract][Full Text] [Related]
15. Targeting MicroRNAs in Prostate Cancer Radiotherapy.
Ni J; Bucci J; Chang L; Malouf D; Graham P; Li Y
Theranostics; 2017; 7(13):3243-3259. PubMed ID: 28900507
[TBL] [Abstract][Full Text] [Related]
16. miR‑199a‑3p/Sp1/LDHA axis controls aerobic glycolysis in testicular tumor cells.
Zhou S; Min Z; Sun K; Qu S; Zhou J; Duan H; Liu H; Liu X; Gong Z; Li D
Int J Mol Med; 2018 Oct; 42(4):2163-2174. PubMed ID: 30015851
[TBL] [Abstract][Full Text] [Related]
17. Proteomics of the radioresistant phenotype in head-and-neck cancer: Gp96 as a novel prediction marker and sensitizing target for radiotherapy.
Lin TY; Chang JT; Wang HM; Chan SH; Chiu CC; Lin CY; Fan KH; Liao CT; Chen IH; Liu TZ; Li HF; Cheng AJ
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):246-56. PubMed ID: 20615631
[TBL] [Abstract][Full Text] [Related]
18. PGC1β regulates multiple myeloma tumor growth through LDHA-mediated glycolytic metabolism.
Zhang H; Li L; Chen Q; Li M; Feng J; Sun Y; Zhao R; Zhu Y; Lv Y; Zhu Z; Huang X; Xie W; Xiang W; Yao P
Mol Oncol; 2018 Sep; 12(9):1579-1595. PubMed ID: 30051603
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.
Sheng SL; Liu JJ; Dai YH; Sun XG; Xiong XP; Huang G
FEBS J; 2012 Oct; 279(20):3898-910. PubMed ID: 22897481
[TBL] [Abstract][Full Text] [Related]
20. Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.
Wang J; Wang H; Liu A; Fang C; Hao J; Wang Z
Oncotarget; 2015 Aug; 6(23):19456-68. PubMed ID: 26062441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
